COVID-19 Daily Updates

UK approves emergency use of Oxford-AstraZeneca COVID-19 vaccine

December 30, 2020, 1:55 PM

Sneha Shah | London

Pascal Soriot, CEO of AstraZeneca

Pascal Soriot, CEO of AstraZeneca

In a first, pharma major AstraZenecas COVID-19 vaccine, which has been developed in partnership with Oxford University, got a green flag for emergency use in United Kingdom, on Wednesday.

In 2020, teams across AstraZeneca have risen to the challenges COVID-19 has posed to global health. Today’s advancement is a significant step forward in the fight against this pandemic, a tweet from official AstraZenecas twitter handle read.

Today in the UK, Medicines and Healthcare products Regulatory Agency (MHRA) has approved our COVID-19 vaccine for emergency supply, CEO of AstraZeneca Pascal Soriot said in a statement.

It is an important day for millions of people in the UK, who will get access to this new vaccine, which has been shown to be effective, well-tolerated, simple to administer and is supplied by AstraZeneca at no profit, he said.

Soriot announced that the vaccinations would begin early in 2021. ?Working with the UK government, first vaccinations will begin early in the New Year, and we aim to supply millions of doses by end of March, he said.

My sincere thanks to our many colleagues at AstraZeneca, Oxford University, the UK government and the tens of thousands of clinical trial participants, he added.

The Authorisation recommends two doses administered within an interval of between four and 12 weeks. This regimen was shown in clinical trials to be safe and effective at preventing symptomatic COVID-19, with no severe cases and no hospitalizations more than 14 days after the second dose, AstraZeneca said.

Also read : COVID-19 vaccine to be given to 51 lakh Delhiites in 1st round: CM Kejriwal

The vaccines can be stored, transported and handled at normal refrigerated conditions (two-eight degree Celsius) for at least six months and administered within existing healthcare settings, the company added.

Daily Updates

Active COVID cases near 30,000 mark in Nagpur

Published

4 years ago

January 25, 2022

Radhika Dhawad | Nagpur

Nagpur’s COVID-19 tally, on Tuesday, January 25, reached 5,43,064 (till 5 pm) as 4028 (972 from rural and 2956 from city) new cases were recorded in a single day.

Also, active COVID cases, as on Tuesday, could be seen inching closer to 30,000 mark in the district.

Six people lost their lives (one from rural and five from city) on Tuesday. Till now, 10,183 people have lost their lives due to COVID-19 in the district. Total tests taken were 11,377.

While patients who recovered on Tuesday were 2519, the total number of recovered patients stood at 503729.

Daily Updates

Nagpur reports 90 COVID cases in past 24 hours

Published

4 years ago

January 2, 2022

Radhika Dhawad | Nagpur

Nagpur’s COVID-19 tally on Sunday, January 2 reached 4,94,193 (till 5 pm) as 90 (73 city, nine rural) more people tested positive for the virus.

Also, five patients recovered on Sunday taking the number of recoveries to 4,83,664.

Till now, 10123 people have lost their lives due to COVID in the district. As of now, there are 406 active COVID patients in the district.

Daily Updates

ALARMING! Nagpur reports 88 COVID cases in past 24 hours

Published

4 years ago

December 31, 2021

Radhika Dhawad | Nagpur

Nagpur registered 88 (81 from city) new COVID-19 positive cases on Friday, December 31. Nagpur previously had recorded as minimum as six cases on December 24.